atypical-antipsychotic

The U.S. Food and Drug Administration (FDA) announced this past week that two types of Seroquel-brand (quetiapine fumarate) atypical antipsychotic medications have been approved for two different mental health treatments — for use as an add-on treatment for depression, and for pediatric schizophrenia and bipolar mania. The FDA approved once-daily Seroquel XR (quetiapine fumarate) Extended ……click here to continue reading